Effect of antiretroviral drug (arved) on hepatic enzymes in albino rats

In the rush to put as many patients as possible on a potent ART, with very little or no laboratory monitory, limited attention has been given to side effects. This study was therefore designed to evaluate the effects of antiretroviral drugs arved® , on aspartate amino transferase (AST), alanine ami...

Full description

Bibliographic Details
Main Authors: D E Peters, A A Uwakwe, C C Monago
Format: Article
Language:English
Published: Joint Coordination Centre of the World Bank assisted National Agricultural Research Programme (NARP) 2014-07-01
Series:Journal of Applied Sciences and Environmental Management
Subjects:
Online Access:https://www.ajol.info/index.php/jasem/article/view/105463
_version_ 1797227920187457536
author D E Peters
A A Uwakwe
C C Monago
author_facet D E Peters
A A Uwakwe
C C Monago
author_sort D E Peters
collection DOAJ
description In the rush to put as many patients as possible on a potent ART, with very little or no laboratory monitory, limited attention has been given to side effects. This study was therefore designed to evaluate the effects of antiretroviral drugs arved® , on aspartate amino transferase (AST), alanine amino transferase (ALT) and alkaline phosphatase (ALP) activities as well as histological effect on the liver tissue. A total of fifty two (52) albino rats were randomly divided into four groups labeled A, B, C and D and kept in a well ventilated room. All experimental groups shared the same environmental conditions. Group A served as the control and rats were treated with distil water. Rats in groups B, C and D were, respectively treated with three different doses of arved (1.07, 3.21, and 4.29 mg kg-1), The drug was administered orally daily for 2, 4, 6, and 8 consecutive weeks. Animals were sacrificed twenty four hours after the last treatment. Blood samples were collected into heparinized sample bottles for biochemical analysis. Result obtained in this study revealed that arved dose and time dependently, significantly (P<0.05) showed higher AST activity with the highest activity observed in treatment group D in wk8, (149.50±1.91 IU/L) when compared to the control group. The mean value of ALT activity for the drug in dose dependent manner was observed to be significantly (P<0.05) higher when compared to control value. The activity was highest in week 2 treatment group D (58.50±2.65). The drug dose dependently, produced significantly (P<0.05) higher ALP activity when compared to the control ALP activity. The highest activity was observed in week 2 treatment group D (214.50±14.75) when compared to the control group A. The histopathological observation of liver tissues showed no morphological change in group D treated for 8 weeks as well as the control group. The rats had no morphologic evidence of hepatocellular necrosis or degeneration. In conclusion, treatment of HIV/AIDS patients with arved may likely result to liver damage possibly cholestatic liver injury at prolonged treatment. Keywords: HIV; AIDs; Antiretroviral Drugs; Arved; Zidovudine; Lamivudine; Alkaline phosphate (ALP); Aspartate amino transferase (AST); Alanine amino transferase (ALT); hepatocellular necrosis
first_indexed 2024-04-24T14:48:28Z
format Article
id doaj.art-b6dd80b4f765495b8679956dfc3a1659
institution Directory Open Access Journal
issn 2659-1502
2659-1499
language English
last_indexed 2024-04-24T14:48:28Z
publishDate 2014-07-01
publisher Joint Coordination Centre of the World Bank assisted National Agricultural Research Programme (NARP)
record_format Article
series Journal of Applied Sciences and Environmental Management
spelling doaj.art-b6dd80b4f765495b8679956dfc3a16592024-04-02T19:53:34ZengJoint Coordination Centre of the World Bank assisted National Agricultural Research Programme (NARP)Journal of Applied Sciences and Environmental Management2659-15022659-14992014-07-0118210.4314/jasem.v18i2.28Effect of antiretroviral drug (arved) on hepatic enzymes in albino ratsD E PetersA A UwakweC C Monago In the rush to put as many patients as possible on a potent ART, with very little or no laboratory monitory, limited attention has been given to side effects. This study was therefore designed to evaluate the effects of antiretroviral drugs arved® , on aspartate amino transferase (AST), alanine amino transferase (ALT) and alkaline phosphatase (ALP) activities as well as histological effect on the liver tissue. A total of fifty two (52) albino rats were randomly divided into four groups labeled A, B, C and D and kept in a well ventilated room. All experimental groups shared the same environmental conditions. Group A served as the control and rats were treated with distil water. Rats in groups B, C and D were, respectively treated with three different doses of arved (1.07, 3.21, and 4.29 mg kg-1), The drug was administered orally daily for 2, 4, 6, and 8 consecutive weeks. Animals were sacrificed twenty four hours after the last treatment. Blood samples were collected into heparinized sample bottles for biochemical analysis. Result obtained in this study revealed that arved dose and time dependently, significantly (P<0.05) showed higher AST activity with the highest activity observed in treatment group D in wk8, (149.50±1.91 IU/L) when compared to the control group. The mean value of ALT activity for the drug in dose dependent manner was observed to be significantly (P<0.05) higher when compared to control value. The activity was highest in week 2 treatment group D (58.50±2.65). The drug dose dependently, produced significantly (P<0.05) higher ALP activity when compared to the control ALP activity. The highest activity was observed in week 2 treatment group D (214.50±14.75) when compared to the control group A. The histopathological observation of liver tissues showed no morphological change in group D treated for 8 weeks as well as the control group. The rats had no morphologic evidence of hepatocellular necrosis or degeneration. In conclusion, treatment of HIV/AIDS patients with arved may likely result to liver damage possibly cholestatic liver injury at prolonged treatment. Keywords: HIV; AIDs; Antiretroviral Drugs; Arved; Zidovudine; Lamivudine; Alkaline phosphate (ALP); Aspartate amino transferase (AST); Alanine amino transferase (ALT); hepatocellular necrosis https://www.ajol.info/index.php/jasem/article/view/105463HIVAIDsAntiretroviral DrugsArvedZidovudineLamivudine
spellingShingle D E Peters
A A Uwakwe
C C Monago
Effect of antiretroviral drug (arved) on hepatic enzymes in albino rats
Journal of Applied Sciences and Environmental Management
HIV
AIDs
Antiretroviral Drugs
Arved
Zidovudine
Lamivudine
title Effect of antiretroviral drug (arved) on hepatic enzymes in albino rats
title_full Effect of antiretroviral drug (arved) on hepatic enzymes in albino rats
title_fullStr Effect of antiretroviral drug (arved) on hepatic enzymes in albino rats
title_full_unstemmed Effect of antiretroviral drug (arved) on hepatic enzymes in albino rats
title_short Effect of antiretroviral drug (arved) on hepatic enzymes in albino rats
title_sort effect of antiretroviral drug arved on hepatic enzymes in albino rats
topic HIV
AIDs
Antiretroviral Drugs
Arved
Zidovudine
Lamivudine
url https://www.ajol.info/index.php/jasem/article/view/105463
work_keys_str_mv AT depeters effectofantiretroviraldrugarvedonhepaticenzymesinalbinorats
AT aauwakwe effectofantiretroviraldrugarvedonhepaticenzymesinalbinorats
AT ccmonago effectofantiretroviraldrugarvedonhepaticenzymesinalbinorats